Purinergic signalling in the nervous system: an overview

  title={Purinergic signalling in the nervous system: an overview},
  author={Maria Pia Abbracchio and Geoffrey Burnstock and Alexei Verkhratsky and Herbert Zimmermann},
  journal={Trends in Neurosciences},

Figures and Tables from this paper

Purinoceptors on Neuroglia

An in depth overview of purinoceptor distribution in two types of CNS glia—in astrocytes and oligodendrocyte—is provided and their physiological and pathophysiological roles are discussed.

Biology of purinergic signalling: Its ancient evolutionary roots, its omnipresence and its multiple functional significance

The purinergic signalling system, which utilises ATP, related nucleotides and adenosine as transmitter molecules, appeared very early in evolution: release mechanisms and ATP‐degrading enzymes are

P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System

The numerous studies indicate a potential possibility of using synthetic agonists/antagonists of P2 receptors in treatment of selected nervous system diseases, which is of particular significance, since numerous available agents reveal a low effectiveness and often produce side effects.

Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death

The purinergic signalling system, which uses purines and pyrimidines as chemical transmitters, and purinoceptors as effectors, is deeply rooted in evolution and development and is a pivotal factor in

From purines to purinergic signalling: molecular functions and human diseases

Profound understanding of molecular mechanisms of purinergic signalling provides new and exciting insights into the treatment of human diseases.

The role of purinergic receptors in retinal function and disease.

The role of purinergic receptors in neuronal signaling and bi-directional glial-neuronal communication in the retina will be considered and elevations in extracellular ATP may lead to apoptosis of retinal neurons.

Introduction to Purinergic Signaling.

There is a growing understanding about the pathophysiology of purinergic signaling and there are therapeutic developments for a variety of diseases, including stroke and thrombosis, osteoporosis, pain, chronic cough, kidney failure, bladder incontinence, cystic fibrosis, dry eye, cancer, and disorders of the CNS, including Alzheimer's, Parkinson's.

Purinergic signaling and the functioning of the nervous system cells

Understanding mechanisms and the fact that P2 receptors and their ligands are involved in the pathogenesis of diseases of the nervous system may help in the design of drugs with different and more effective mechanisms of action.



Purinergic signalling and disorders of the central nervous system

  • G. Burnstock
  • Biology, Psychology
    Nature Reviews Drug Discovery
  • 2008
The role of purinergic signalling in CNS disorders is reviewed, highlighting specificPurinergic receptor subtypes, most notably A2A, P2X4 and P2 X7, that might be therapeutically targeted for the treatment of these conditions.

Purinergic signalling: pathophysiological roles.

The protective roles of nucleosides and nucleotides in events such as cancer, ischemia, wound healing, drug toxicity, inflammation and pain are explored and some suggestions made for future developments in this rapidly expanding field of purinergic receptor subtypes.

Purinergic transmission in the central nervous system

The adenosine 5′-triphosphate (ATP), discovered in 1929 by Karl Lohman, Cyrus Hartwell Fiske, and Yellagaprada SubbaRow, acts as an important extracellular signaling molecule that binds to a plethora of ionotropic and metabotropic receptors, which mediate its action as an excitatory neurotransmitter.

Purinergic modulation of synaptic signalling at the neuromuscular junction

Recent developments in understanding of purinergic modulation of the NMJ are discussed with an emphasis on the involvement of purines in neuron-glia interactions at this synapse.

Physiology and pathophysiology of purinergic neurotransmission.

This review is focused on purinergic neurotransmission, i.e., ATP released from nerves as a transmitter or cotransmitter to act as an extracellular signaling molecule on both pre- and postjunctional

P2 receptor-mediated modulation of neurotransmitter release—an update

The rapidly emerging data on the modulation of transmitter release by facilitatory and inhibitory P2 receptors and the receptor subtypes involved in these interactions are reviewed.

Purinergic signaling and microglia

The purinoreceptors also modulate the release of substances from microglia, such as cytokines, nitric oxide, or superoxide, which are important in the context of a pathologic response.

Ectonucleotidases in the nervous system.

Members of several families of ectonucleotidases can contribute to extracellular nucleotide hydrolysis and proposed physiological functions include modulation of synaptic transmission, of the ATP-mediated propagation of glial Ca2+ waves, of microglial function, adult neurogenesis or the control of vascular tone, haemostasis and thromboregulation.